Materials • Major Chemicals
$48.32 ▼ -0.53
(-1.08%)
MKT CAP: $5.30B • VOL: 1.30M
52W L $35 52W H $71
CE // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $9.54B | $10.27B | $10.93B |
| YoY Revenue Growth % | -7.1% | -6.0% | — |
| Gross Profit | $1.95B | $2.34B | $4.81B |
| Gross Margin % | 20.5% | 22.8% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$786.0M | -$720.0M | $1.67B |
| Operating Margin % | -8.2% | -7.0% | 15.2% |
| Net Income (GAAP) | -$1.17B | -$1.54B | $1.94B |
| EBITDA (Normalized) | -$511.6M | -$372.0M | $2.06B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.15B | $966.0M | $1.90B |
| Capital Expenditures (CapEx) | $343.0M | $435.0M | $491.7M |
| Free Cash Flow (FCF) | $803.0M | $531.0M | $1.41B |
| FCF Margin % | 8.4% | 5.2% | 12.9% |
| Return on Invested Capital (ROIC %) | -9.2% | -7.1% | 16.6% |
| Cash & Short-Term Equivalents | $2.39B | $2.51B | $1.44B |
| Total Debt (Short + Long Term) | $5.08B | $5.34B | $3.07B |
| Total Stockholders' Equity | $4.05B | $5.13B | $6.29B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CE.